Fig. 3
From: Long term treatment with ataluren—the Swedish experience
3a Change in predicted FVC (%) per patient over time (n = 10). The rate of expected change in predicted FVC (%) is adjusted by Mayer et al. 2015: Advances in pulmonary care in Duchenne Muscular Dystrophy [10]. 3b Length of time periods on ataluren treatment per patient (n = 10). Age at discontinuation of treatment with ataluren is indicated with a black triangle for patients 2, 4 and 7